These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17923866)

  • 21. Staging the tumor and staging the host: A two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer.
    Park JH; Ishizuka M; McSorley ST; Kubota K; Roxburgh CSD; Nagata H; Takagi K; Iwasaki Y; Aoki T; Horgan PG; McMillan DC
    Am J Surg; 2018 Sep; 216(3):458-464. PubMed ID: 28967380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer.
    Moyes LH; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Br J Cancer; 2009 Apr; 100(8):1236-9. PubMed ID: 19319134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer.
    Suzuki Y; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Kondo T; Kitagawa Y
    Ann Surg; 2018 Mar; 267(3):527-531. PubMed ID: 27984214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients.
    Golder AM; McMillan DC; Park JH; Mansouri D; Horgan PG; Roxburgh CS
    Br J Cancer; 2021 May; 124(11):1828-1835. PubMed ID: 33762720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.
    Takamizawa Y; Shida D; Boku N; Nakamura Y; Ahiko Y; Yoshida T; Tanabe T; Takashima A; Kanemitsu Y
    BMC Cancer; 2020 Nov; 20(1):1092. PubMed ID: 33176752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
    McSorley ST; Tham A; Steele CW; Dolan RD; Roxburgh CS; Horgan PG; McMillan DC
    Eur J Surg Oncol; 2019 Jul; 45(7):1205-1211. PubMed ID: 30850153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
    Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer.
    Richards CH; Leitch EF; Horgan PG; Anderson JH; McKee RF; McMillan DC
    Br J Cancer; 2010 Oct; 103(9):1356-61. PubMed ID: 20877354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
    Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of nomogram based on pre-treatment inflammatory markers in patients with pulmonary-only synchronous metastases from colorectal cancer.
    Chen L; Li Q; Wang Y; Yang J; Ma X
    Int Immunopharmacol; 2019 Dec; 77():106001. PubMed ID: 31734191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Follow-Up of Patients Undergoing Resection of TNM Stage I Colorectal Cancer: An Analysis of Tumour and Host Determinants of Outcome.
    Mansouri D; Powell AG; Park JH; McMillan DC; Horgan PG
    World J Surg; 2016 Jun; 40(6):1485-91. PubMed ID: 26920405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma.
    Farhan-Alanie OM; McMahon J; McMillan DC
    Br J Oral Maxillofac Surg; 2015 Feb; 53(2):126-31. PubMed ID: 25440150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.
    Crozier JE; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Am J Surg; 2009 Apr; 197(4):544-9. PubMed ID: 18614139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer.
    Knight K; Choong JX; McKee RF; Anderson JH; Horgan PG; McMillan DC; McDonald A; Roxburgh CS
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e22-e30. PubMed ID: 32709540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer.
    Leung EY; Crozier JE; Talwar D; O'Reilly DS; McKee RF; Horgan PG; McMillan DC
    Int J Cancer; 2008 Nov; 123(10):2460-4. PubMed ID: 18729200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
    Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
    Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic Inflammation and Outcome in 2295 Patients with Stage I-III Colorectal Cancer from Scotland and Norway: First Results from the ScotScan Colorectal Cancer Group.
    Park JH; Fuglestad AJ; Køstner AH; Oliwa A; Graham J; Horgan PG; Roxburgh CSD; Kersten C; McMillan DC
    Ann Surg Oncol; 2020 Aug; 27(8):2784-2794. PubMed ID: 32248375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.